AI USE CASE
Clinical Trial Enrollment ML Optimizer
Identify eligible patients and optimize site selection to accelerate clinical trial enrollment using ML.
What it is
Machine learning models analyze electronic health records, claims data, and demographic profiles to predict which patients are likely to qualify and enroll in clinical trials. By combining patient-level eligibility scoring with site performance analytics, sponsors can reduce enrollment timelines by 20–40% and cut screen-failure rates significantly. Optimized site selection ensures resources are concentrated where recruitment is fastest, potentially saving millions in trial delays. This approach can compress overall trial duration and improve data quality by targeting truly representative patient populations.
Data you need
Electronic health records (EHR), patient claims data, historical trial enrollment records, and site performance metrics across previous studies.
Required systems
- data warehouse
- erp
Why it works
- Early engagement with data privacy and regulatory teams to establish compliant data access pipelines before model development begins.
- Close collaboration between data scientists and clinical operations staff to ensure model features reflect real-world eligibility criteria.
- Continuous retraining of models with enrollment outcomes from ongoing trials to improve predictive accuracy over time.
- Phased rollout starting with one therapeutic area to demonstrate ROI before scaling across the full trial portfolio.
How this goes wrong
- EHR data is fragmented across incompatible systems, making it impossible to build a reliable patient eligibility dataset.
- Model predictions are biased by historically underrepresented demographic groups in prior trial data, skewing site and patient targeting.
- Regulatory and privacy constraints (GDPR, HIPAA) delay or block access to the patient-level data needed to train accurate models.
- Clinical operations teams distrust algorithmic recommendations and revert to manual site and patient selection, negating the tool's value.
When NOT to do this
Do not pursue this if your organization lacks unified, longitudinal patient data and has no established data-sharing agreements with clinical sites, as the model will have insufficient signal to outperform experienced clinical operations staff.
Vendors to consider
Sources
This use case is part of a larger Data & AI catalog built from 50+ enterprise transformation programs. Take the free diagnostic to see how it ranks against your specific context.